Study Links Changes in Brain Glymphatic Function and Network Connectivity to Autism Prognosis

October 17, 2026 2 Min Read

New Insights Into Autism Spectrum Disorder Brain Function

A recent longitudinal study has explored how alterations in the brain’s glymphatic system and functional network connectivity (FNC) relate to clinical outcomes in children with autism spectrum disorder (ASD). The research suggests that these brain measures may serve as promising biomarkers for tracking symptom progression and prognosis in ASD.

Study Design and Participants

The investigation combined cross-sectional and two-year follow-up analyses involving 50 children diagnosed with ASD and 50 typically developing controls. Researchers assessed glymphatic function using two imaging-based metrics: the along the perivascular space (ALPS) index and global blood-oxygen-level-dependent to cerebrospinal fluid (gBOLD-CSF) coupling. Functional network connectivity was also evaluated to understand brain network interactions.

Key Findings on Glymphatic Function and Network Connectivity

At the initial assessment, children with ASD exhibited significantly lower ALPS index and gBOLD-CSF coupling values compared to controls, indicating reduced glymphatic function. Additionally, widespread decreases in functional network connectivity were observed in the ASD group.

During the two-year follow-up, 40 ASD participants were reassessed. Results showed an overall increase in glymphatic function over time among these children. Notably, greater improvements in the ALPS index correlated with more substantial reductions in autism symptom severity, as measured by the Autism Diagnostic Observation Schedule calibrated severity score (ADOS-CSS).

Within the subgroup of children whose symptoms improved, four specific functional network connections, including those between the default mode network (DMN) and dorsal attention network (DAN), strengthened over time. Conversely, no consistent connectivity changes were detected in children without symptom improvement.

Implications for Prognosis and Future Research

Baseline measures of inter-network connectivity showed associations with symptom improvement in simpler analyses, although these relationships did not hold in more complex multivariate models. Mediation analysis revealed an indirect link between initial gBOLD-CSF coupling and long-term symptom reduction mediated by changes in DMN-DAN connectivity.

These findings highlight that both glymphatic function and functional brain networks are altered in ASD but may improve alongside clinical symptoms. This suggests potential utility for these imaging markers in predicting and monitoring ASD prognosis.

Considerations and Limitations

While the study provides valuable longitudinal data, the sample size for follow-up was limited to 40 ASD participants, and causal relationships cannot be definitively established. Further research is needed to validate these biomarkers and understand their mechanistic roles in ASD.

For more detailed information, see the original study published in Psychiatry and Clinical Neurosciences at https://pubmed.ncbi.nlm.nih.gov/42888514/.